For Immediate Release
October 5, 2021
Cranford, NJ – Steve Brozak, DMH, Managing Partner and President of WBB Securities will moderate a panel titled “Manufacturing: The Next Big COVID Problem or Worse?” at the BioFuture conference on Wednesday, October 6, 2021.
The panel will address how COVID-19 has exposed critical vulnerabilities in medical supply chains, and today’s manufacturing inability to keep up with scientific innovation, medical discovery, and the need to rapidly produce and distribute critically important drugs at scale. Panelists will address how manufacturing companies are committed to tackling these huge problems with a new business model and how new technology is broadening access to novel therapies and vaccines while protecting supply chains against disruption.
Panel participants include:
- Chandresh Harjivan, COO, SaponiQx
- Tyler Martin, MD, CEO, Adjuvance
- Molly McGlaughlin, Former COO, Vigene Biosciences
- Kurt Nielsen, PhD, President & CEO, Pii
In addition to managing the firm, Dr. Brozak serves as WBB’s Senior Equity Analyst. He is an award-winning analyst whose research has been singled out from his peers for accuracy and performance year after year by the financial industry’s most highly regarded rankings organizations. His research is currently monitored by the Bloomberg, StarMine and FactSet platforms.
Registration for either in-person or virtual access to this and other presentations can be accessed at Registration | BioFuture | Healthcare and Technology Conference 2021
About WBB Securities.
WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily in the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer and is a member of FINRA, as well as a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.
About BioFuture.
BioFuture is where relentless pioneers, innovators and entrepreneurs gather to assess the present and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s inaugural summit, They will explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
